Hidden Risk, Clear Guidance: Strategies for Excellence in Atherosclerotic Cardiovascular Disease (ASCVD) Prevention
Elevated lipoprotein(a) is an important cardiovascular risk factor that can substantially contribute to ASCVD risk beyond standard measures. However, translating Lp(a) findings into clinical management can remain challenging in everyday practice.
This webcast, featuring presentations from our ESC Congress 2026 satellite symposium in Munich together with additional clinical cases and key practical questions, explores the role of Lp(a) in ASCVD risk assessment and provides evidence-based, patient-centered strategies for managing patients with elevated Lp(a).
28 August 2026
Munich, Germany
From Risk Stratification to Action – Intensifying Prevention Through Evidence-Based and Patient-Centered ASCVD Management
Speaker: Prof. Klaus Parhofer
München, Germany
Lectures
Prof. Lale Tokgözoglu
Ankara, Turkey
Beyond Standard Risk Factors – Identifying Hidden ASCVD Risk and Recognizing the Role of Lp(a)
Watch LectureProf. Klaus Parhofer
München, Germany
From Risk Stratification to Action – Intensifying Prevention Through Evidence-Based and Patient-Centered ASCVD Management
Current LectureProf. Cristina Gavina
Porto, Portugal
Lp(a) in Clinical Practice: Cases, Challenges and Clinical Decisions
Watch LectureProf. Florian Kronenberg
Innsbruck, Austria
From Evidence to Understanding: Key Questions for Clinical Practice
Watch LectureAn application for accreditation has been submitted to the EACCME®.